Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 58 entries
Sorted by: Best Match Show Resources per page
[Personal experience in endosseous implants after a few years].

Dental Cadmos

de Vecchi M.
PMID: 350648
Dent Cadmos. 1977 Aug;45(8):3-11.

No abstract available.

Cite
de Vecchi M. Considerazioni su una casistica personale di impianti endoossei a distanza di alcuni anni. [Personal experience in endosseous implants after a few years]. Dent Cadmos. 1977;45(8):3-11
de Vecchi, M. (1977). Considerazioni su una casistica personale di impianti endoossei a distanza di alcuni anni. [Personal experience in endosseous implants after a few years]. Dental Cadmos, 45(8), 3-11.
de Vecchi, M. "Considerazioni su una casistica personale di impianti endoossei a distanza di alcuni anni." [Personal experience in endosseous implants after a few years]. Dental Cadmos vol. 45,8 (1977): 3-11.
de Vecchi M. Considerazioni su una casistica personale di impianti endoossei a distanza di alcuni anni. [Personal experience in endosseous implants after a few years]. Dent Cadmos. 1977 Aug;45(8):3-11. Italian. PMID: 350648.
Copy Download .nbib Format: NLM
ANTIBIOTIC-LOADED REGENOSS FOR THE TREATMENT OF SEPTIC BONE DEFECTS: IN VITRO STUDY AND PRELIMINARY CLINICAL EXPERIENCE.

Journal of biological regulators and homeostatic agents

Romano' CL, Gallazzi E, Logoluso N, De Vecchi E, Drago L.
PMID: 26652496
J Biol Regul Homeost Agents. 2015 Oct-Dec;29(4):103-10.

Bone and joint infections are a difficult to treat condition, often associated with bone loss. Although the management of septic bone defects may currently be achieved through various treatment modalities, there is a continuous need for bone substitutes able...

Cite
Romano' CL, Gallazzi E, Logoluso N, et al. ANTIBIOTIC-LOADED REGENOSS FOR THE TREATMENT OF SEPTIC BONE DEFECTS: IN VITRO STUDY AND PRELIMINARY CLINICAL EXPERIENCE. J Biol Regul Homeost Agents. 2015;29(4):103-10
Romano', C. L., Gallazzi, E., Logoluso, N., De Vecchi, E., & Drago, L. (2015). ANTIBIOTIC-LOADED REGENOSS FOR THE TREATMENT OF SEPTIC BONE DEFECTS: IN VITRO STUDY AND PRELIMINARY CLINICAL EXPERIENCE. Journal of biological regulators and homeostatic agents, 29(4), 103-10.
Romano', C L, et al. "ANTIBIOTIC-LOADED REGENOSS FOR THE TREATMENT OF SEPTIC BONE DEFECTS: IN VITRO STUDY AND PRELIMINARY CLINICAL EXPERIENCE." Journal of biological regulators and homeostatic agents vol. 29,4 (2015): 103-10.
Romano' CL, Gallazzi E, Logoluso N, De Vecchi E, Drago L. ANTIBIOTIC-LOADED REGENOSS FOR THE TREATMENT OF SEPTIC BONE DEFECTS: IN VITRO STUDY AND PRELIMINARY CLINICAL EXPERIENCE. J Biol Regul Homeost Agents. 2015 Oct-Dec;29(4):103-10. PMID: 26652496.
Copy Download .nbib Format: NLM
Editorial: Ventricular Mechanics in Congenital Heart Disease.

Frontiers in pediatrics

Biglino G, de Vecchi A.
PMID: 28620598
Front Pediatr. 2017 May 31;5:129. doi: 10.3389/fped.2017.00129. eCollection 2017.

No abstract available.

Cite
Biglino G, de Vecchi A. Editorial: Ventricular Mechanics in Congenital Heart Disease. Front Pediatr. 2017;5:129doi: 10.3389/fped.2017.00129.
Biglino, G., & de Vecchi, A. (2017). Editorial: Ventricular Mechanics in Congenital Heart Disease. Frontiers in pediatrics, 5129. https://doi.org/10.3389/fped.2017.00129
Biglino, Giovanni, and de Vecchi, Adelaide. "Editorial: Ventricular Mechanics in Congenital Heart Disease." Frontiers in pediatrics vol. 5 (2017): 129. doi: https://doi.org/10.3389/fped.2017.00129
Biglino G, de Vecchi A. Editorial: Ventricular Mechanics in Congenital Heart Disease. Front Pediatr. 2017 May 31;5:129. doi: 10.3389/fped.2017.00129. eCollection 2017. PMID: 28620598; PMCID: PMC5449435.
Copy Download .nbib Format: NLM
Hyaluronic Acid and Its Composites as a Local Antimicrobial/Antiadhesive Barrier.

Journal of bone and joint infection

Romanò CL, De Vecchi E, Bortolin M, Morelli I, Drago L.
PMID: 28529865
J Bone Jt Infect. 2017 Jan 01;2(1):63-72. doi: 10.7150/jbji.17705. eCollection 2017.

Living in biofilms is probably the most common condition for bacteria and fungi and biofilm-related infections account for the majority of bacterial infectious diseases worldwide. Among others biofilm-related infections, those associated with implanted biomaterials have an enormous and still...

Cite
Romanò CL, De Vecchi E, Bortolin M, et al. Hyaluronic Acid and Its Composites as a Local Antimicrobial/Antiadhesive Barrier. J Bone Jt Infect. 2017;2(1):63-72doi: 10.7150/jbji.17705.
Romanò, C. L., De Vecchi, E., Bortolin, M., Morelli, I., & Drago, L. (2017). Hyaluronic Acid and Its Composites as a Local Antimicrobial/Antiadhesive Barrier. Journal of bone and joint infection, 2(1), 63-72. https://doi.org/10.7150/jbji.17705
Romanò, C L, et al. "Hyaluronic Acid and Its Composites as a Local Antimicrobial/Antiadhesive Barrier." Journal of bone and joint infection vol. 2,1 (2017): 63-72. doi: https://doi.org/10.7150/jbji.17705
Romanò CL, De Vecchi E, Bortolin M, Morelli I, Drago L. Hyaluronic Acid and Its Composites as a Local Antimicrobial/Antiadhesive Barrier. J Bone Jt Infect. 2017 Jan 01;2(1):63-72. doi: 10.7150/jbji.17705. eCollection 2017. PMID: 28529865; PMCID: PMC5423572.
Copy Download .nbib Format: NLM
[Therapeutic and prophylactic role of mesalazine (5-ASA) in symptomatic diverticular disease of the large intestine. 4 year follow-up results].

Minerva gastroenterologica e dietologica

Trepsi E, Colla C, Panizza P, Polino MG, Venturini A, Bottani G, De Vecchi P, Matti C.
PMID: 16498335
Minerva Gastroenterol Dietol. 1999 Dec;45(4):245-52.

In order to evaluate the efficacy and tolerability of mesalazine (5-ASA) in the prophylaxis of symptomatic relapses, of major complications and of microhemorrhagic phenomena in diverticular disease of the large intestine (MDC), prospective clinical study was conducted on patients...

Cite
Trepsi E, Colla C, Panizza P, et al. Ruolo terapeutico e profilattico della mesalazina (5-ASA) nella malattia diverticolare sintomatica del crasso. Risultati a 4 anni di follow-up. [Therapeutic and prophylactic role of mesalazine (5-ASA) in symptomatic diverticular disease of the large intestine. 4 year follow-up results]. Minerva Gastroenterol Dietol. 1999;45(4):245-52
Trepsi, E., Colla, C., Panizza, P., Polino, M. G., Venturini, A., Bottani, G., De Vecchi, P., & Matti, C. (1999). Ruolo terapeutico e profilattico della mesalazina (5-ASA) nella malattia diverticolare sintomatica del crasso. Risultati a 4 anni di follow-up. [Therapeutic and prophylactic role of mesalazine (5-ASA) in symptomatic diverticular disease of the large intestine. 4 year follow-up results]. Minerva gastroenterologica e dietologica, 45(4), 245-52.
Trepsi, E, et al. "Ruolo terapeutico e profilattico della mesalazina (5-ASA) nella malattia diverticolare sintomatica del crasso. Risultati a 4 anni di follow-up." [Therapeutic and prophylactic role of mesalazine (5-ASA) in symptomatic diverticular disease of the large intestine. 4 year follow-up results]. Minerva gastroenterologica e dietologica vol. 45,4 (1999): 245-52.
Trepsi E, Colla C, Panizza P, Polino MG, Venturini A, Bottani G, De Vecchi P, Matti C. Ruolo terapeutico e profilattico della mesalazina (5-ASA) nella malattia diverticolare sintomatica del crasso. Risultati a 4 anni di follow-up. [Therapeutic and prophylactic role of mesalazine (5-ASA) in symptomatic diverticular disease of the large intestine. 4 year follow-up results]. Minerva Gastroenterol Dietol. 1999 Dec;45(4):245-52. Italian. PMID: 16498335.
Copy Download .nbib Format: NLM
The effect of ranolazine on maintaining sinus rhythm in patients with resistant atrial fibrillation.

Indian pacing and electrophysiology journal

Murdock DK, Overton N, Kersten M, Kaliebe J, Devecchi F.
PMID: 18679523
Indian Pacing Electrophysiol J. 2008 Aug 01;8(3):175-81.

BACKGROUND: Atrial fibrillation (AF) may arise out of anomalous impulse activity at atrial venous junctions. Triggered activity may be a source of abnormal impulse activity. Ranolazine is an anti-anginal agent, which inhibits normal and abnormal late Na+ channel current...

Cite
Murdock DK, Overton N, Kersten M, et al. The effect of ranolazine on maintaining sinus rhythm in patients with resistant atrial fibrillation. Indian Pacing Electrophysiol J. 2008;8(3):175-81
Murdock, D. K., Overton, N., Kersten, M., Kaliebe, J., & Devecchi, F. (2008). The effect of ranolazine on maintaining sinus rhythm in patients with resistant atrial fibrillation. Indian pacing and electrophysiology journal, 8(3), 175-81.
Murdock, David K, et al. "The effect of ranolazine on maintaining sinus rhythm in patients with resistant atrial fibrillation." Indian pacing and electrophysiology journal vol. 8,3 (2008): 175-81.
Murdock DK, Overton N, Kersten M, Kaliebe J, Devecchi F. The effect of ranolazine on maintaining sinus rhythm in patients with resistant atrial fibrillation. Indian Pacing Electrophysiol J. 2008 Aug 01;8(3):175-81. PMID: 18679523; PMCID: PMC2490806.
Copy Download .nbib Format: NLM
Synthesis and spectroscopic-electrochemical properties of novel ratiometric Hg (II) chemosensor containing Bodipy and the N-phenylaza-15-crown-5 moiety.

Journal of luminescence

Kursunlu AN, Deveci P, Guler E.
PMID: 24496245
J Lumin. 2013 Apr 01;136:430-436. doi: 10.1016/j.jlumin.2012.12.020.

The aryl-amine containing azacrown ether ring and alkyl-chloro boradiazaindacene (Bodipy) were synthesized by Schiff base condensation. The absorption and emission of a novel Schiff base derivative (based on azacrown-Bodipy ) were performed in presence of different cations such as...

Cite
Kursunlu AN, Deveci P, Guler E. Synthesis and spectroscopic-electrochemical properties of novel ratiometric Hg (II) chemosensor containing Bodipy and the N-phenylaza-15-crown-5 moiety. J Lumin. 2013;136:430-436doi: 10.1016/j.jlumin.2012.12.020.
Kursunlu, A. N., Deveci, P., & Guler, E. (2013). Synthesis and spectroscopic-electrochemical properties of novel ratiometric Hg (II) chemosensor containing Bodipy and the N-phenylaza-15-crown-5 moiety. Journal of luminescence, 136430-436. https://doi.org/10.1016/j.jlumin.2012.12.020
Kursunlu, Ahmed Nuri, et al. "Synthesis and spectroscopic-electrochemical properties of novel ratiometric Hg (II) chemosensor containing Bodipy and the N-phenylaza-15-crown-5 moiety." Journal of luminescence vol. 136 (2013): 430-436. doi: https://doi.org/10.1016/j.jlumin.2012.12.020
Kursunlu AN, Deveci P, Guler E. Synthesis and spectroscopic-electrochemical properties of novel ratiometric Hg (II) chemosensor containing Bodipy and the N-phenylaza-15-crown-5 moiety. J Lumin. 2013 Apr 01;136:430-436. doi: 10.1016/j.jlumin.2012.12.020. PMID: 24496245; PMCID: PMC3564662.
Copy Download .nbib Format: NLM
Genome sequence of a hepatitis e virus of genotype 3e from a chronically infected kidney transplant recipient.

Genome announcements

Moal V, Ferretti A, Devichi P, Colson P.
PMID: 24482510
Genome Announc. 2014 Jan 30;2(1). doi: 10.1128/genomeA.01156-13.

Hepatitis E virus (HEV) is an emerging cause of acute and chronic hepatitis in immunocompromised patients in Europe. We report the genome sequence of a genotype 3e HEV from a chronically infected kidney transplant recipient in southeastern France, the...

Cite
Moal V, Ferretti A, Devichi P, et al. Genome sequence of a hepatitis e virus of genotype 3e from a chronically infected kidney transplant recipient. Genome Announc. 2014;2(1)doi: 10.1128/genomeA.01156-13.
Moal, V., Ferretti, A., Devichi, P., & Colson, P. (2014). Genome sequence of a hepatitis e virus of genotype 3e from a chronically infected kidney transplant recipient. Genome announcements, 2(1), . https://doi.org/10.1128/genomeA.01156-13
Moal, Valérie, et al. "Genome sequence of a hepatitis e virus of genotype 3e from a chronically infected kidney transplant recipient." Genome announcements vol. 2,1 (2014). doi: https://doi.org/10.1128/genomeA.01156-13
Moal V, Ferretti A, Devichi P, Colson P. Genome sequence of a hepatitis e virus of genotype 3e from a chronically infected kidney transplant recipient. Genome Announc. 2014 Jan 30;2(1). doi: 10.1128/genomeA.01156-13. PMID: 24482510; PMCID: PMC3907725.
Copy Download .nbib Format: NLM
Chiral bosons and improper constraints.

Physical review. D, Particles and fields

Devecchi FP, Girotti HO.
PMID: 10017437
Phys Rev D Part Fields. 1994 Apr 15;49(8):4302-4305. doi: 10.1103/physrevd.49.4302.

No abstract available.

Cite
Devecchi FP, Girotti HO. Chiral bosons and improper constraints. Phys Rev D Part Fields. 1994;49(8):4302-4305doi: 10.1103/physrevd.49.4302.
Devecchi, F. P., & Girotti, H. O. (1994). Chiral bosons and improper constraints. Physical review. D, Particles and fields, 49(8), 4302-4305. https://doi.org/10.1103/physrevd.49.4302
Devecchi, and Girotti. "Chiral bosons and improper constraints." Physical review. D, Particles and fields vol. 49,8 (1994): 4302-4305. doi: https://doi.org/10.1103/physrevd.49.4302
Devecchi FP, Girotti HO. Chiral bosons and improper constraints. Phys Rev D Part Fields. 1994 Apr 15;49(8):4302-4305. doi: 10.1103/physrevd.49.4302. PMID: 10017437.
Copy Download .nbib Format: NLM
Usefulness and Limitations of Comprehensive Characterization of mRNA Splicing Profiles in the Definition of the Clinical Relevance of .

Cancers

Gelli E, Colombo M, Pinto AM, De Vecchi G, Foglia C, Amitrano S, Morbidoni V, Imperatore V, Manoukian S, Baldassarri M, Lo Rizzo C, Catania L, Frullanti E, Tagliafico E, Cortesi L, Spaggiari F, Mencarelli MA, Trevisson E, Radice P, Renieri A, Ariani F.
PMID: 30832263
Cancers (Basel). 2019 Mar 01;11(3). doi: 10.3390/cancers11030295.

Highly penetrant variants of

Cite
Gelli E, Colombo M, Pinto AM, et al. Usefulness and Limitations of Comprehensive Characterization of mRNA Splicing Profiles in the Definition of the Clinical Relevance of . Cancers (Basel). 2019;11(3)doi: 10.3390/cancers11030295.
Gelli, E., Colombo, M., Pinto, A. M., De Vecchi, G., Foglia, C., Amitrano, S., Morbidoni, V., Imperatore, V., Manoukian, S., Baldassarri, M., Lo Rizzo, C., Catania, L., Frullanti, E., Tagliafico, E., Cortesi, L., Spaggiari, F., Mencarelli, M. A., Trevisson, E., Radice, P., Renieri, A., & Ariani, F. (2019). Usefulness and Limitations of Comprehensive Characterization of mRNA Splicing Profiles in the Definition of the Clinical Relevance of . Cancers, 11(3), . https://doi.org/10.3390/cancers11030295
Gelli, Elisa, et al. "Usefulness and Limitations of Comprehensive Characterization of mRNA Splicing Profiles in the Definition of the Clinical Relevance of ." Cancers vol. 11,3 (2019). doi: https://doi.org/10.3390/cancers11030295
Gelli E, Colombo M, Pinto AM, De Vecchi G, Foglia C, Amitrano S, Morbidoni V, Imperatore V, Manoukian S, Baldassarri M, Lo Rizzo C, Catania L, Frullanti E, Tagliafico E, Cortesi L, Spaggiari F, Mencarelli MA, Trevisson E, Radice P, Renieri A, Ariani F. Usefulness and Limitations of Comprehensive Characterization of mRNA Splicing Profiles in the Definition of the Clinical Relevance of . Cancers (Basel). 2019 Mar 01;11(3). doi: 10.3390/cancers11030295. PMID: 30832263; PMCID: PMC6468917.
Copy Download .nbib Format: NLM
The Use of Biophysical Flow Models in the Surgical Management of Patients Affected by Chronic Thromboembolic Pulmonary Hypertension.

Frontiers in physiology

Spazzapan M, Sastry P, Dunning J, Nordsletten D, de Vecchi A.
PMID: 29593574
Front Physiol. 2018 Mar 13;9:223. doi: 10.3389/fphys.2018.00223. eCollection 2018.

No abstract available.

Cite
Spazzapan M, Sastry P, Dunning J, et al. The Use of Biophysical Flow Models in the Surgical Management of Patients Affected by Chronic Thromboembolic Pulmonary Hypertension. Front Physiol. 2018;9:223doi: 10.3389/fphys.2018.00223.
Spazzapan, M., Sastry, P., Dunning, J., Nordsletten, D., & de Vecchi, A. (2018). The Use of Biophysical Flow Models in the Surgical Management of Patients Affected by Chronic Thromboembolic Pulmonary Hypertension. Frontiers in physiology, 9223. https://doi.org/10.3389/fphys.2018.00223
Spazzapan, Martina, et al. "The Use of Biophysical Flow Models in the Surgical Management of Patients Affected by Chronic Thromboembolic Pulmonary Hypertension." Frontiers in physiology vol. 9 (2018): 223. doi: https://doi.org/10.3389/fphys.2018.00223
Spazzapan M, Sastry P, Dunning J, Nordsletten D, de Vecchi A. The Use of Biophysical Flow Models in the Surgical Management of Patients Affected by Chronic Thromboembolic Pulmonary Hypertension. Front Physiol. 2018 Mar 13;9:223. doi: 10.3389/fphys.2018.00223. eCollection 2018. PMID: 29593574; PMCID: PMC5859070.
Copy Download .nbib Format: NLM
[No title available]

Frontiers in microbiology

Bortolin M, Bidossi A, De Vecchi E, Avveniente M, Drago L.
PMID: 28642751
Front Microbiol. 2017 Jun 08;8:1039. doi: 10.3389/fmicb.2017.01039. eCollection 2017.

Skin and soft tissue infections

Cite
Bortolin M, Bidossi A, De Vecchi E, et al. . Front Microbiol. 2017;8:1039doi: 10.3389/fmicb.2017.01039.
Bortolin, M., Bidossi, A., De Vecchi, E., Avveniente, M., & Drago, L. (2017). . Frontiers in microbiology, 81039. https://doi.org/10.3389/fmicb.2017.01039
Bortolin, Monica, et al. "." Frontiers in microbiology vol. 8 (2017): 1039. doi: https://doi.org/10.3389/fmicb.2017.01039
Bortolin M, Bidossi A, De Vecchi E, Avveniente M, Drago L. . Front Microbiol. 2017 Jun 08;8:1039. doi: 10.3389/fmicb.2017.01039. eCollection 2017. PMID: 28642751; PMCID: PMC5462991.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 58 entries